Welcome!

News Feed Item

The Zacks Analyst Blog Highlights: Fidelity Select Health Care Fund, Fidelity Select Pharmaceuticals, Fidelity Select Medical Equipment and Systems Portfolio, Icon Healthcare Fund and Fidelity Select Medical Delivery

CHICAGO, Aug. 22, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Fidelity Select Health Care Fund (FSPHX-Free Report), Fidelity Select Pharmaceuticals (FPHAX-Free Report), Fidelity Select Medical Equipment and Systems Portfolio (FSMEX-Free Report), Icon Healthcare Fund (ICHCX-Free Report) and Fidelity Select Medical Delivery (FSHCX-Free Report).

Zacks Investment Research, Inc., www.zacks.com.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Thursday's Analyst Blog:

5 Healthcare Mutual Funds Riding High on Earnings

With most of the Q2 2014 filings in the books, the medical sector has posted the top year to date earnings growth out of all the 16 Zacks sectors.  The sector as a whole is showing 15.6% year over year earnings growth.   

Further, the medical sector posted very impressive year over year revenue growth as well; 12.3% for Q2 2014.  Further, more than 75% of the companies in the medical sector beat their earnings and revenue expectations this quarter. 

While the earnings and revenue numbers are very impressive, we are now looking towards the second half of 2014, and into 2015.  Currently, we expect the medical sector to post double digit earnings growth for 2014, and 2015; 12.9% for 2014, and 12.4% in 2015. 

On the Revenue front, the medical sector is expected to post double digit growth in 2014, and then see some pull back in 2015; 10.9% for 2014, and 5.2% for 2015. 

Due to the positive Q2 results, and future guidance, we believe a wise investor should look to some strongly performing Healthcare Mutual Funds to capture the sectors growth through 2015.  We utilized the Zacks Mutual Fund Ranking system to identify the best positioned and best performing healthcare funds. 

To better understand the Zacks Mutual Fund Ranking System, please click here

Top Healthcare Mutual Funds

Fidelity Select Health Care Fund (FSPHX-Free Report) a Zacks Rank #1 (Strong Buy) is a balanced allocated fund, that holds about 48% of their position in the healthcare sector, with the remainder spread out multiple different industries including Tech, Finance, Industrial, and Services.  The fund is comprised of companies that are principally engaged in the design, manufacture, or sale of products or services used for or in connection with healthcare or medicine.  This gives the fund a broader spectrum of companies, and enables it to withstand headwinds more efficiently. 

The fund is heavy companies like, Actavis, Biogen, McKesson, Boston Scientific, and Agilent Technologies.  This fund as a minimum investment of $2,500, and is not front loaded (fees). 

Past Performance: 1 year 49.80%, 3 year 27.19%, 5 year 27.23%

Fidelity Select Pharmaceuticals (FPHAX-Free Report) a Zacks Rank #1 (Strong Buy) is much heavier in the health sector, with just under 69% of the fund, than our previous recommendation.  This fund invests in companies that are engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.  This fund was opened in 2001, and has strong 10 year return: 13.81%, vs. S&P 500 10 year at 8.3%.

The fund is heavy Abbvie, Merk, Johnson & Johnson, Astrazeneca, and Bristol Myers.  The fund has a minimum investment of $2,500, and is not front loaded (fees). 

Past Performance: 1 year 39.26%, 3 year 22.77%, 5 year 24.14%

Fidelity Select Medical Equipment and Systems Portfolio (FSMEX-Free Report) a Zacks Rank #1 (Strong Buy) is over weighted in the health sector, with at least 80% of their assets in common stocks of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment and devices and related technologies.  Currently, the portfolio is just below 65% in health sector, with the remainder spread amongst Finance, Technology, Other, Retail trade, Services, and Industrial.  This fund was started in 1998, and has posted strong 10 year returns (+11.84%), which have outperformed the S&P 500 at 8.3%. 

The fund is heavy Covidien, Boston Scientific, Stryker Corp, Abbott Labs, and Medtronic.  The fund has a minimum investment of $2,500, and is not front loaded. 

Past Performance: 1 year 35.34%, 3 year 16.32%, 5 year 18.53%.

Icon Healthcare Fund (ICHCX-Free Report) a Zacks Rank #1 (Strong Buy) is a more balanced healthcare mutual fund, with just under 32% of the fund in the health sector.  This fund diversifies itself with other sectors who are related to the healthcare sector, with large holdings in Other, Finance, Services, Retail trade, Industrial, and non-durable sectors.  This fund is relatively inexpensive to enter, with only $1,000 minimum initial investment, and zero front loaded fees.  In the past 10 years, the fund has outperformed the S&P 500 by posting returns of 10.75% vs 8.3%.

This fund has the greatest percentage of their fund in Johnson & Johnson, Gilead, Celgene, Cigna, and UnitedHealth group.

Past Performance: 1 year 30.11%, 3 year 20.50%, 5 year 20.32%.

Fidelity Select Medical Delivery (FSHCX-Free Report) a Zacks Rank #1 (Strong Buy) who's objective is to seek out capital appreciation.  The fund normally invests at least 80% of assets in common stocks of companies principally engaged in the ownership or management of hospitals, nursing homes, health maintenance organizations, and other companies specializing in the delivery of health care services.  The fund offers dividends and capital gains twice a year in April and December.   This fund was started in 1986, and has outperformed the S&P 500 over the past 10 years, 15.73% vs. 8.3%. 

The fund is heavy UnitedHealth Group, Express Scripts, McKesson, Cardinal Health, and Cigna Corp.  FSHCX has a minimum investment of $2,500, and is not front loaded. 

Past Performance: 1 year 25.12%, 3 year 13.74%, 5 year 21.87%. 

Bottom Line

The healthcare sector is positioned for sustained earnings and revenue growth out through 2015.  So if you are inclined to invest into the healthcare sector, you should look to add these highly performing mutual funds to your portfolio.  

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on FSPHX - FREE

Get the full Report on FPHAX - FREE

Get the full Report on FSMEX - FREE

Get the full Report on ICHCX - FREE

Get the full Report on FSHCX - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Logo - http://photos.prnewswire.com/prnh/20101027/ZIRLOGO

SOURCE Zacks Investment Research, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that CrowdReviews.com has been named “Media Sponsor” of SYS-CON's 22nd International Cloud Expo, which will take place on June 5–7, 2018, at the Javits Center in New York City, NY. CrowdReviews.com is a transparent online platform for determining which products and services are the best based on the opinion of the crowd. The crowd consists of Internet users that have experienced products and services first-hand and have an interest in letting other potential buye...
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
Transformation Abstract Encryption and privacy in the cloud is a daunting yet essential task for both security practitioners and application developers, especially as applications continue moving to the cloud at an exponential rate. What are some best practices and processes for enterprises to follow that balance both security and ease of use requirements? What technologies are available to empower enterprises with code, data and key protection from cloud providers, system administrators, inside...
Modern software design has fundamentally changed how we manage applications, causing many to turn to containers as the new virtual machine for resource management. As container adoption grows beyond stateless applications to stateful workloads, the need for persistent storage is foundational - something customers routinely cite as a top pain point. In his session at @DevOpsSummit at 21st Cloud Expo, Bill Borsari, Head of Systems Engineering at Datera, explored how organizations can reap the bene...
We are seeing a major migration of enterprises applications to the cloud. As cloud and business use of real time applications accelerate, legacy networks are no longer able to architecturally support cloud adoption and deliver the performance and security required by highly distributed enterprises. These outdated solutions have become more costly and complicated to implement, install, manage, and maintain.SD-WAN offers unlimited capabilities for accessing the benefits of the cloud and Internet. ...
"IBM is really all in on blockchain. We take a look at sort of the history of blockchain ledger technologies. It started out with bitcoin, Ethereum, and IBM evaluated these particular blockchain technologies and found they were anonymous and permissionless and that many companies were looking for permissioned blockchain," stated René Bostic, Technical VP of the IBM Cloud Unit in North America, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventi...
In his session at 20th Cloud Expo, Scott Davis, CTO of Embotics, discussed how automation can provide the dynamic management required to cost-effectively deliver microservices and container solutions at scale. He also discussed how flexible automation is the key to effectively bridging and seamlessly coordinating both IT and developer needs for component orchestration across disparate clouds – an increasingly important requirement at today’s multi-cloud enterprise.
You want to start your DevOps journey but where do you begin? Do you say DevOps loudly 5 times while looking in the mirror and it suddenly appears? Do you hire someone? Do you upskill your existing team? Here are some tips to help support your DevOps transformation. Conor Delanbanque has been involved with building & scaling teams in the DevOps space globally. He is the Head of DevOps Practice at MThree Consulting, a global technology consultancy. Conor founded the Future of DevOps Thought Leade...
Security, data privacy, reliability and regulatory compliance are critical factors when evaluating whether to move business applications from in-house client hosted environments to a cloud platform. In her session at 18th Cloud Expo, Vandana Viswanathan, Associate Director at Cognizant, In this session, will provide an orientation to the five stages required to implement a cloud hosted solution validation strategy.
"Calligo is a cloud service provider with data privacy at the heart of what we do. We are a typical Infrastructure as a Service cloud provider but it's been designed around data privacy," explained Julian Box, CEO and co-founder of Calligo, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Jo Peterson is VP of Cloud Services for Clarify360, a boutique sourcing and benchmarking consultancy focused on transforming technology into business advantage. Clarify360 provides custom, end-to-end solutions from a portfolio of more than 170 suppliers globally. As an engineer, Jo sources net new technology footprints, and is an expert at optimizing and benchmarking existing environments focusing on Cloud Enablement and Optimization. She and her team work with clients on Cloud Discovery, Cloud ...
DXWordEXPO New York 2018, colocated with CloudEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
In an era of historic innovation fueled by unprecedented access to data and technology, the low cost and risk of entering new markets has leveled the playing field for business. Today, any ambitious innovator can easily introduce a new application or product that can reinvent business models and transform the client experience. In their Day 2 Keynote at 19th Cloud Expo, Mercer Rowe, IBM Vice President of Strategic Alliances, and Raejeanne Skillern, Intel Vice President of Data Center Group and G...